Cresco Labs Inc. (OTCMKTS:CRLBF) Receives $2.50 Consensus Price Target from Analysts

Cresco Labs Inc. (OTCMKTS:CRLBF) has been given a consensus rating of “Moderate Buy” by the seven ratings firms that are presently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating, two have given a buy rating and two have assigned a strong buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $2.50.

CRLBF has been the topic of a number of research analyst reports. Ventum Cap Mkts raised Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th. Needham & Company LLC reissued a “hold” rating on shares of Cresco Labs in a report on Monday, August 12th. Cormark cut shares of Cresco Labs from a “moderate buy” rating to a “hold” rating in a research note on Monday, November 11th. Finally, Roth Capital upgraded shares of Cresco Labs to a “strong-buy” rating in a research note on Sunday, November 10th.

Cresco Labs Price Performance

OTCMKTS:CRLBF opened at $1.09 on Monday. The stock has a market cap of $533.29 million, a PE ratio of -5.46 and a beta of 1.88. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80. The business’s 50-day simple moving average is $1.52 and its two-hundred day simple moving average is $1.66. Cresco Labs has a 52 week low of $1.02 and a 52 week high of $2.65.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.